Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 80,000 shares at $19.96 ($1.6M) on 2023-12-20, disclosed to the SEC on 2023-12-22.
Scheduled sale ($1.6M) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.96 | 9,443 | $188K | 11.6% |
| 2 | $19.96 | 9,443 | $188K | 11.6% |
| 3 | $20.36 | 30,557 | $622K | 38.4% |
| 4 | $20.36 | 30,557 | $622K | 38.4% |
| Total | $20.27 avg | 80,000 | $1.6M | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |